Pharmaceuticals

Hemophilia cases are fueling the Jivi Market 2026

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Jivi Market Between 2026 And 2030?

The expansion observed during the historic timeframe was primarily a consequence of frequent bleeding episodes experienced by hemophilia A patients, the inherent limitations of conventional factor VIII treatments, the prompt adoption of recombinant factors, an increased emphasis on preventing joint damage, and the expansion of hemophilia treatment centers.

Anticipated growth during the forecast period is fueled by the heightened adoption of long-acting clotting factors, expanded availability of home infusion services, broader provision of pediatric hemophilia care, encouraging reimbursement frameworks, and pioneering advancements in recombinant therapies.

Key trends identified for the forecast period comprise the increasing embrace of extended half-life factor VIII, a transition towards preventative hemophilia management, a preference for less frequent injections, the expansion of home-based hemophilia care, and enhanced patient compliance with treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20117&type=smp

What Key Drivers Are Influencing The Growth Of The Jivi Market?

The increasing occurrence of hemophilia is anticipated to boost the expansion of the jivi market in the future. Hemophilia arises from genetic alterations in X-linked genes crucial for clotting factor production, resulting in inadequate or faulty clotting factors VIII (hemophilia A) or IX (hemophilia B), which hinder effective blood clotting. The incidence of hemophilia is rising due to enhanced diagnostic methods, greater public awareness, and more reported cases globally. Jivi supports hemophilia patients by substituting the missing Factor VIII with a long-acting recombinant treatment, thereby assisting blood coagulation to avoid or manage bleeding episodes. Its prolonged half-life also decreases dosing frequency, improving patient convenience and compliance. For instance, in April 2025, according to Hemophilia News Today, a US-based medical news platform, the estimated number of individuals living with hemophilia worldwide reached approximately 836,000, including about 284,000 people with the severe form of the disorder. Consequently, the growing prevalence of hemophilia is fueling the growth of the jivi market.

Which Market Segments Are Examined In The Jivi Market Study?

The jivi market covered in this report is segmented –

1) By Formulation: Lyophilized Powder For Reconstitution, Ready-to-use Formulations

2) By Route of Administration: Intravenous, Subcutaneous

3) By Indication: Treatment Of Hemophilia A, Prophylaxis, On-demand Treatment For Bleeding Episodes

4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies

5) By End Use: Hospitals, Hemophilia Treatment Centres, Specialty Clinics, Home Healthcare Settings

Who Are The Primary Competitors In The Jivi Market?

Major companies operating in the jivi market are Bayer AG

Read the full jivi market report here:

https://www.thebusinessresearchcompany.com/report/jivi-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Jivi Market?

North America was the largest region in the jivi market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the jivi market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Jivi Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20117&type=smp

Browse Through More Reports Similar to the Global Jivi Market 2026, By The Business Research Company

Financial Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/financial-analytics-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Vertical Market Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/vertical-market-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795